S89900 |
BTdCPU |
源叶(MedMol) | 98% |
- 产品描述: BTdCPU is a potent heme regulated inhibitor kinase (HRI) activator that promotes eIF2α phosphorylation and induces apoptosis in Dexamethasone (HY-14648) (Dex)-resistant cancer cells. BTdCPU can be used in the study of cancers such as multiple myeloma and Dex-resistant multiple myeloma
- 靶点: HRI
- 体内研究: BTdCPU (175 mg/kg; i.p.; single daily for 21 days) inhibits tumor growth without toxicity in mice xenograft breast tumors model. Animal Model: Female nude mice (mice xenograft breast tumors model). Dosage: 175 mg/kg Administration: Intraperitoneal injection; single daily for 21 days Result: Led to complete tumor stasis,which persisted for the remainder of the 3-week studyShowed good safety in mice.
- 参考文献:
1. Burwick N, et al. The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma. Leuk Res. 2017 Apr;55:23-32. 2. Chen T, et al. Chemical genetics identify eIF2α kinase heme-regulated inhibitor as an anticancer target. Nat Chem Biol. 2011 Jul 17;7(9):610-6.
- 溶解性: Soluble in DMSO
- 保存条件: -20℃
- 配置溶液浓度参考:
1mg 5mg 10mg 1 mM 2.948 ml 14.741 ml 29.481 ml 5 mM 0.59 ml 2.948 ml 5.896 ml 10 mM 0.295 ml 1.474 ml 2.948 ml 50 mM 0.059 ml 0.295 ml 0.59 ml
- 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)